Preparation of Nanostructured Lipid Carriers (NLCs) Loading Violacein Extract for Anti-Acne Products

Abstract:

The objective of this research is to evaluate the antimicrobial activity of Nanostructured Lipid Carriers (NLCs) loading violacein extract. The extract was tested for the antimicrobial activities against 3 strains of pathogenic bacteria; namely Cutibacterium acnes ATCC 6919, Staphylococcus aureus ATCC 6538 and Staphylococcus epidermidis ATCC 12228 by agar well diffusion assay. The result indicated that the violacein extract from Chromobacterium violaceum ATCC 12472 has strongest antibacterial effect against C. acnes, S. aureus and S. epidermidis with MIC values in range of 0.0146-0.4688 mg/mL with the lowest MBC value of 0.0146 mg/mL against C. acnes. Violacein extract loaded Nanostructured Lipid Carriers (NLCs) for anti-acne products were prepared by using melt-emulsification technique. The studied factors are the ratio of liquid lipid and solid lipid (LL:SL), surfactant concentration and sonication time. The Ratio of Oleic acid and Compritol^® 888 ATO (3:1) with Tween 20 (1.5% w/w) and sonication time of 10 minute (F8 formulation) are an optimizing condition for NLC-Base. The resulted formulations showed the NLC-Base had average particle size of 213.7±2.42 nm with a polydispersity index of 0.239±0.003 and Zeta potential of -26.6±0.45 mV. After that, violacein extract (2% w/w) was loaded into the NLCs (VIO-NLCs). Antibacterial activity of VIO-NLCs 2 % was determined by using agar dilution. The result showed that VIO-NLCs 2 % can inhibit the growth of C. acnes for 60 days during storage. Furthermore, VIO-NLCs 2 % can also act as S. aureus and S. epidermidis inhibitor within 30 days shelf life.

• Periodical: Key Engineering Materials (Volume 901)
• Pages: 129-136
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.901.129
• Online since: October 2021
• Authors: Pornphan Leelaudomlipi, Somkamol Manchun*, Piyaporn Supakdamrongkul, Parapat Sobharaksha
• Keywords: Antibacterial Activity, Melt-Emulsification Technique, Nanostructured Lipid Carriers (NLCs), Violacein Extract

References

[1] M.N. Eshtiaghi, J. Kuldiloke, Formulation of antiacne cream containing natural antimicrobials, Int. Res. J. Pharm. 11 (2013) 20-25.

[2] M.G. Gopal, B. Farahana, Effectiveness of Herbal Medications in the Treatment of Acne Vulgaris – A Pilot Study, Indian Pract. 54 (2001) 723-728.

[3] W. Gübelin, M. Martínez, M.T. Molina, S. Zapata, M.E. Valenzuela, Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne, Rev Latinoam Microbiol. 48 (2006) 14-16.

[4] Y. Lovecková, I. Havlíková, A Microbiological approach to acne vulgaris, Biomed. Papers. 146 (2002) 29-32.

[5] K.S. Dhillon, K.R. Varshney, Study of Microbiological Spectrum in Acne Vulgaris: An In Vitro Study, Sch. J. App. Med. Sci. 1 (2013) 724-727.

[6] C.J. Lee, L.W. Chen, L.G. Chen, T.L. Chang, C.W. Huang, M.C. Huang, C.C. Wang, Correlations of the components of tea tree oil with its antibacterial effects and skin irritation, JFDA. 21 (2013) 169-176.

DOI: 10.1016/j.jfda.2013.05.007

[7] W. Musial, A. Kubis, Preliminary assessment of alginic acid as a factor buffering triethanolamine interacting with artificial skin sebum, Eur J Pharm Biopharm. 55 (2003) 237-240.

DOI: 10.1016/s0939-6411(02)00195-9

[8] R. Riveros, M. Haun, V. Campos, N. Durán, Complete characterization of violacein: an antibiotic and trypanocide pigment from Chromobacterium violaceum, J Biol Technol. 31 (1998) 475-487.

[9] D.D. Carvalho, T.M. Costa, N. Durán, M. Huan, Cytotoxicity activity of violacein in human colon cancer cells, J.Toxicology in Vitro. 20 (2006) 1514-1521.

DOI: 10.1016/j.tiv.2006.06.007

[10] J. Pardeike, A. Hommoss, R.Hf. Müller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int J Pharm. 366 (2009) 170-184.

DOI: 10.1016/j.ijpharm.2008.10.003

[11] F.R. Cockerill, J.A. Hindler, M.A. Wikler, J.B. Patel, J. Alder, et al, Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-ninth edition. CLSI document M07-A9, 2012, pp.13-16.

[12] N. Durán, G.Z. Justo, M. Durán, M Brocchi, Advances in Chromobacterium violaceum and properties of violacein-Its main secondary metabolite: A review, Biotechnol Adv. 34 (2016) 1030-1045.

DOI: 10.1016/j.biotechadv.2016.06.003

[13] F.Q. Hu, S.P. Jiang, Y.Z. Du, H. Yuan, Y.Q. Ye, S. Zeng, Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system, Colloids Surf B Biointerfaces. 45 (2005) 167-173.

DOI: 10.1016/j.colsurfb.2005.08.005

[14] R. Müeller, S. Maaβen, H. Weyhers, F. Specht, J. S. Lucks, Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles, Int J Pharm. 138 (1996) 85-94.

DOI: 10.1016/0378-5173(96)04539-5

[15] S. Das, W.K. Ng, B.H. Tan, Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs, Eur J Pharm Sci. 47 (2012) 139-151.

DOI: 10.1016/j.ejps.2012.05.010

[16] M. Üner, Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems, Pharmazie. 61 (2006) 375-386.